| Rachel A Jansen, DO | |
|
4379 Ridgewood Center Dr Ste 102, Woodbridge, VA 22192 | |
| (703) 680-7950 | |
| Not Available |
| Full Name | Rachel A Jansen |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 4379 Ridgewood Center Dr Ste 102, Woodbridge, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952453482 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 0102201988 (Virginia) | Primary |
| Entity Name | University Of Virginia Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033138250 PECOS PAC ID: 4880590728 Enrollment ID: O20040102000780 |
News Archive
Scientists have identified a protein that acts as a "master switch" in certain white blood cells, determining whether they promote or inhibit inflammation. The study, published in the journal Nature Immunology, could help researchers look for new treatments for diseases such as rheumatoid arthritis that involve excessive inflammation.
Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the worldwide launch of the SILS™ Stitch articulating suturing device for advanced laparoscopic surgery, including SILS single-incision procedures. The SILS Stitch instrument expands the Company's SILS product line, as well as its endoscopic suturing portfolio, which includes today's leading automated endosuturing product, the Endo Stitch™ instrument and reloads.
Inadequate cleansing of the colon has an adverse effect on procedure time, safety, completion rate and diagnostic accuracy.
Men with type 2 diabetes are less likely to develop prostate cancer than patients without diabetes. However, the mortality rate is higher.
Idera Pharmaceuticals, Inc., today announced that it has achieved a milestone under its worldwide licensing and collaboration agreement with Merck KGaA, Darmstadt, Germany. The milestone was achieved upon initiation of a Phase 2 trial by Merck KGaA of EMD 1201081, a novel agonist of Toll-like Receptor 9 (TLR9), in combination with cetuximab (Erbitux®) in second-line cetuximab-naïve patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
› Verified 8 days ago
| Entity Name | Greater Prince William Area Community Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366591562 PECOS PAC ID: 9436258209 Enrollment ID: O20070619000479 |
News Archive
Scientists have identified a protein that acts as a "master switch" in certain white blood cells, determining whether they promote or inhibit inflammation. The study, published in the journal Nature Immunology, could help researchers look for new treatments for diseases such as rheumatoid arthritis that involve excessive inflammation.
Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the worldwide launch of the SILS™ Stitch articulating suturing device for advanced laparoscopic surgery, including SILS single-incision procedures. The SILS Stitch instrument expands the Company's SILS product line, as well as its endoscopic suturing portfolio, which includes today's leading automated endosuturing product, the Endo Stitch™ instrument and reloads.
Inadequate cleansing of the colon has an adverse effect on procedure time, safety, completion rate and diagnostic accuracy.
Men with type 2 diabetes are less likely to develop prostate cancer than patients without diabetes. However, the mortality rate is higher.
Idera Pharmaceuticals, Inc., today announced that it has achieved a milestone under its worldwide licensing and collaboration agreement with Merck KGaA, Darmstadt, Germany. The milestone was achieved upon initiation of a Phase 2 trial by Merck KGaA of EMD 1201081, a novel agonist of Toll-like Receptor 9 (TLR9), in combination with cetuximab (Erbitux®) in second-line cetuximab-naïve patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
› Verified 8 days ago
| Entity Name | Uva Community Health Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023483567 PECOS PAC ID: 4688587967 Enrollment ID: O20110311000151 |
News Archive
Scientists have identified a protein that acts as a "master switch" in certain white blood cells, determining whether they promote or inhibit inflammation. The study, published in the journal Nature Immunology, could help researchers look for new treatments for diseases such as rheumatoid arthritis that involve excessive inflammation.
Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the worldwide launch of the SILS™ Stitch articulating suturing device for advanced laparoscopic surgery, including SILS single-incision procedures. The SILS Stitch instrument expands the Company's SILS product line, as well as its endoscopic suturing portfolio, which includes today's leading automated endosuturing product, the Endo Stitch™ instrument and reloads.
Inadequate cleansing of the colon has an adverse effect on procedure time, safety, completion rate and diagnostic accuracy.
Men with type 2 diabetes are less likely to develop prostate cancer than patients without diabetes. However, the mortality rate is higher.
Idera Pharmaceuticals, Inc., today announced that it has achieved a milestone under its worldwide licensing and collaboration agreement with Merck KGaA, Darmstadt, Germany. The milestone was achieved upon initiation of a Phase 2 trial by Merck KGaA of EMD 1201081, a novel agonist of Toll-like Receptor 9 (TLR9), in combination with cetuximab (Erbitux®) in second-line cetuximab-naïve patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
› Verified 8 days ago
| Entity Name | Obhg Virginia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972807394 PECOS PAC ID: 9436323342 Enrollment ID: O20111110000430 |
News Archive
Scientists have identified a protein that acts as a "master switch" in certain white blood cells, determining whether they promote or inhibit inflammation. The study, published in the journal Nature Immunology, could help researchers look for new treatments for diseases such as rheumatoid arthritis that involve excessive inflammation.
Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the worldwide launch of the SILS™ Stitch articulating suturing device for advanced laparoscopic surgery, including SILS single-incision procedures. The SILS Stitch instrument expands the Company's SILS product line, as well as its endoscopic suturing portfolio, which includes today's leading automated endosuturing product, the Endo Stitch™ instrument and reloads.
Inadequate cleansing of the colon has an adverse effect on procedure time, safety, completion rate and diagnostic accuracy.
Men with type 2 diabetes are less likely to develop prostate cancer than patients without diabetes. However, the mortality rate is higher.
Idera Pharmaceuticals, Inc., today announced that it has achieved a milestone under its worldwide licensing and collaboration agreement with Merck KGaA, Darmstadt, Germany. The milestone was achieved upon initiation of a Phase 2 trial by Merck KGaA of EMD 1201081, a novel agonist of Toll-like Receptor 9 (TLR9), in combination with cetuximab (Erbitux®) in second-line cetuximab-naïve patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rachel A Jansen, DO 4379 Ridgewood Center Dr Ste 102, Woodbridge, VA 22192-8323 Ph: (703) 680-7950 | Rachel A Jansen, DO 4379 Ridgewood Center Dr Ste 102, Woodbridge, VA 22192 Ph: (703) 680-7950 |
News Archive
Scientists have identified a protein that acts as a "master switch" in certain white blood cells, determining whether they promote or inhibit inflammation. The study, published in the journal Nature Immunology, could help researchers look for new treatments for diseases such as rheumatoid arthritis that involve excessive inflammation.
Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the worldwide launch of the SILS™ Stitch articulating suturing device for advanced laparoscopic surgery, including SILS single-incision procedures. The SILS Stitch instrument expands the Company's SILS product line, as well as its endoscopic suturing portfolio, which includes today's leading automated endosuturing product, the Endo Stitch™ instrument and reloads.
Inadequate cleansing of the colon has an adverse effect on procedure time, safety, completion rate and diagnostic accuracy.
Men with type 2 diabetes are less likely to develop prostate cancer than patients without diabetes. However, the mortality rate is higher.
Idera Pharmaceuticals, Inc., today announced that it has achieved a milestone under its worldwide licensing and collaboration agreement with Merck KGaA, Darmstadt, Germany. The milestone was achieved upon initiation of a Phase 2 trial by Merck KGaA of EMD 1201081, a novel agonist of Toll-like Receptor 9 (TLR9), in combination with cetuximab (Erbitux®) in second-line cetuximab-naïve patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
› Verified 8 days ago
Dr. Grigor Khachikian, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1950 Opitz Blvd, Woodbridge, VA 22191 Phone: 703-551-4656 Fax: 703-497-4167 | |
Dr. Brad B Swelstad, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 13580 Groupe Dr Ste 105, Woodbridge, VA 22192 Phone: 703-680-1770 Fax: 855-402-1839 | |
Dr. John D Long Jr., MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 14139 Potomac Mills Rd, Kaiser Permanente Woodbridge Medical Center, Woodbridge, VA 22192 Phone: 703-490-8400 Fax: 703-490-7635 | |
Dr. Zohreh Nikkhah Abyaneh, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2026 Opitz Blvd Ste A, Woodbridge, VA 22191 Phone: 571-992-8005 Fax: 703-494-3958 | |
Michael Q Smith, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4379 Ridgewood Center Dr Ste 102, Woodbridge, VA 22192 Phone: 703-680-7950 Fax: 703-680-7953 | |
Jennifer Y Hsu, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 13580 Groupe Dr Ste 105, Woodbridge, VA 22192 Phone: 703-680-1770 Fax: 855-402-1839 | |
Dr. Beverly Waddell-jiggetts, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 14139 Potomac Mills Road, Woodbridge, VA 22192 Phone: 703-490-8400 Fax: 703-490-7701 |